Home
>
National Drug Code (NDC)
>
ESIKA
ESIKA - 13537-353-01 - (Pyrithione Zinc)
Drug Information of ESIKA
| Product NDC: | 13537-353 |
| Proprietary Name: | ESIKA |
| Non Proprietary Name: | Pyrithione Zinc |
| Active Ingredient(s): | .0034 mg/mL & nbsp; Pyrithione Zinc |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ESIKA
| Product NDC: | 13537-353 |
| Labeler Name: | Ventura Corporation (San Juan, P.R) |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part358H |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110517 |
Package Information of ESIKA
| Package NDC: | 13537-353-01 |
| Package Description: | 400 mL in 1 BOTTLE (13537-353-01) |
NDC Information of ESIKA
| NDC Code | 13537-353-01 |
| Proprietary Name | ESIKA |
| Package Description | 400 mL in 1 BOTTLE (13537-353-01) |
| Product NDC | 13537-353 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Pyrithione Zinc |
| Dosage Form Name | LIQUID |
| Route Name | TOPICAL |
| Start Marketing Date | 20110517 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Ventura Corporation (San Juan, P.R) |
| Substance Name | PYRITHIONE ZINC |
| Strength Number | .0034 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
